- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00789932
Cognitive Behavioral Therapy for Core Autism Symptoms in School-Aged Children: A Randomized, Controlled Trial (BIACA-2)
February 1, 2013 updated by: Jeffrey J. Wood, University of California, Los Angeles
This study is designed to examine the efficacy of a cognitive behavioral therapy (CBT) program for treating core autism symptoms, social and emotional problems, and adaptive behavior deficits in children with autism spectrum disorders.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90095
- UCLA
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 11 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion criteria:
- 7 - 11 years of age
- meet research criteria for a diagnosis of autism, Asperger Syndrome, or PDD-NOS
- meet DSM-IV criteria for one of the following anxiety disorders: Separation Anxiety Disorder, Social Phobia, Obsessive-Compulsive Disorder
- If taking medication, have maintained a stable dose for 1 month prior to baseline assessment
Exclusion Criteria:
- child has an IQ of less than 80
- begin taking new medication(s) or current medication dose changes either (1) less than 1 month prior to baseline assessment, or (2) during the study period
- for any reason the child or parents appear unable to participate in the treatment program
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Usual Care
|
16 weeks of community care, 16 weeks of CBT, 1.5 hours/week.
|
|
EXPERIMENTAL: CBT
|
32 weeks of CBT, 1.5 hours weekly.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
ADIS-C/P (Anxiety Disorder Interview Schedule for Children and Parents)
Time Frame: 8 months (post-treatment)
|
8 months (post-treatment)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Behavioral observations of social responsiveness
Time Frame: 8 months (post-treatment)
|
8 months (post-treatment)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Jeffrey Wood, PhD, University of California, Los Angeles
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2008
Primary Completion (ACTUAL)
December 1, 2011
Study Completion (ACTUAL)
December 1, 2011
Study Registration Dates
First Submitted
November 12, 2008
First Submitted That Met QC Criteria
November 12, 2008
First Posted (ESTIMATE)
November 13, 2008
Study Record Updates
Last Update Posted (ESTIMATE)
February 5, 2013
Last Update Submitted That Met QC Criteria
February 1, 2013
Last Verified
February 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OAR-UCLA-2009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.